0001193125-25-253766
SEC filingNotes section text not provided; no data extracted.
No data provided.
No data provided.
No data provided.
No data provided.
Operating cash flow (CFO) for the 39 weeks ended September 27, 2025 was $277.5M, compared to net income (not explicitly provided) which is typically the primary driver. The $37.5M decline from prior year CFO of $315.0M suggests tighter working capital or lower earnings. Capital expenditures (capex) were $10.6M, virtually flat with $11.9M a year ago, indicating consistent investment intensity. Free cash flow (not explicitly stated) would be approximately $266.9M ($277.5M - $10.6M), comfortably covering share repurchases of $54.3M and dividends of $23.5M. The company returned $77.8M to shareholders, down from $103.7M in the prior period. Investing cash flow was negative $12.2M, reflecting capex and other investing activities. Financing cash flow was negative $79.6M, primarily due to share repurchases, dividends, and a reduction in long-term debt. No major anomalies were noted; working capital swings were not detailed but the CFO decrease versus prior year warrants attention.